187 related articles for article (PubMed ID: 31743839)
21. Generation of OCIAD2 homozygous knockout (BJNhem20-OCIAD2-CRISPR-33) and heterozygous knockout (BJNhem20-OCIAD2-CRISPR-40) human embryonic stem cell lines using CRISPR-Cas9 mediated targeting.
Kamat K; Inamdar MS
Stem Cell Res; 2023 Mar; 67():103026. PubMed ID: 36642056
[TBL] [Abstract][Full Text] [Related]
22. Generation of GADD45A gene knockout human embryonic stem cell line using CRISPR/Cas9.
Li J; Li Y; Zhan XY; Ran X; Tse HF; Dang S; Nie Y; Huang K
Stem Cell Res; 2020 Dec; 49():102090. PubMed ID: 33232900
[TBL] [Abstract][Full Text] [Related]
23. Construction of a GLI3 compound heterozygous knockout human embryonic stem cell line WAe001-A-20 by CRISPR/Cas9 editing.
Wei R; Yuan F; Wu Y; Liu Y; You K; Yang Z; Chen Y; Getachew A; Wang N; Xu Y; Zhuang Y; Yang F; Li YX
Stem Cell Res; 2018 Oct; 32():139-144. PubMed ID: 30278376
[TBL] [Abstract][Full Text] [Related]
24. Generation of a KCNJ11 homozygous knockout human embryonic stem cell line WAe001-A-12 using CRISPR/Cas9.
Yuan F; Guo D; Gao G; Liu Y; Xu Y; Wu Y; Yang F; Ke X; Lai K; Hong L; Li YX
Stem Cell Res; 2017 Oct; 24():89-93. PubMed ID: 29034901
[TBL] [Abstract][Full Text] [Related]
25. CRISPR-Cas9 editing of synaptic genes in human embryonic stem cells for functional analysis in induced human neurons.
Houcek A; Ma ZZ; Trauterman B; Uzay B; Monteggia LM; Kavalali ET
STAR Protoc; 2024 Jun; 5(2):103089. PubMed ID: 38795356
[TBL] [Abstract][Full Text] [Related]
26. Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9.
Bara AM; Messana A; Herring A; Hazelbaker DZ; Eggan K; Barrett LE
Stem Cell Res; 2016 Sep; 17(2):441-443. PubMed ID: 27879221
[TBL] [Abstract][Full Text] [Related]
27. Generation of PARP1 gene knockout human embryonic stem cell line using CRISPR/Cas9.
Li Y; Li J; Zhou T; Pan G; Huang K
Stem Cell Res; 2021 May; 53():102288. PubMed ID: 33740642
[TBL] [Abstract][Full Text] [Related]
28. Generation of a PDX1-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-3, using the CRISPR/Cas9 system.
Lee Y; Choi HY; Kwon A; Park H; Park MH; Kim JW; Kim MJ; Kim YO; Kwak S; Koo SK
Stem Cell Res; 2019 Dec; 41():101632. PubMed ID: 31683099
[TBL] [Abstract][Full Text] [Related]
29. Modified CRISPR/Cas9 mediated generation of two MKK7 knockout human embryonic stem cell lines.
Sims CHC; Autio MI; Buskin A; Cheung C; Heer R; Foo RSY; Wang X
Stem Cell Res; 2021 Apr; 52():102238. PubMed ID: 33611044
[TBL] [Abstract][Full Text] [Related]
30. Generation of a MSX1 knockout human embryonic stem cell line using CRISPR/Cas9 technology.
Chiu W; Li A; Wang T; Li W; Zhang X
Stem Cell Res; 2022 Apr; 60():102729. PubMed ID: 35247841
[TBL] [Abstract][Full Text] [Related]
31. Generation of a homozygous GRIN2A gene knockout human embryonic stem cell line using CRISPR/Cas9 system.
Luo X; Yang K; Jiang M; Chen T; Chi Y; Ma B; Lai L; Zou Q
Stem Cell Res; 2023 Jun; 69():103121. PubMed ID: 37182381
[TBL] [Abstract][Full Text] [Related]
32. Generation of Rybp homozygous knockout murine ES cell line GIBHe001-A-1 by using CRISPR/Cas9 technology.
Liu Z; Yao M; Yao H; Hu G; Qin B
Stem Cell Res; 2019 Dec; 41():101638. PubMed ID: 31794887
[TBL] [Abstract][Full Text] [Related]
33. Generation of RAB39B knockout isogenic human embryonic stem cell lines to model RAB39B-mediated Parkinson's disease.
Gao Y; Wilson GR; Bozaoglu K; Elefanty AG; Stanley EG; Dottori M; Lockhart PJ
Stem Cell Res; 2018 Apr; 28():161-164. PubMed ID: 29499499
[TBL] [Abstract][Full Text] [Related]
34. Establishment of a CRISPR/Cas9-mediated ANP32A homozygous knockout human embryonic stem cell line.
Zhang C; Wei Y; Zhang Y; Zhang J; Xing Q; Zhou M; Shan Y
Stem Cell Res; 2021 Apr; 52():102234. PubMed ID: 33607472
[TBL] [Abstract][Full Text] [Related]
35. Generation of an RNF1-deficient human pluripotent stem cell line using CRISPR/Cas9 technology.
Zhang D; Zhou M; Zhang Y; Shan Y; Pan G
Stem Cell Res; 2022 Jul; 62():102809. PubMed ID: 35567848
[TBL] [Abstract][Full Text] [Related]
36. Generation of FOXJ1-EGFP knock-in reporter human embryonic stem cell line, WAe001-A-2D, using CRISPR/Cas9-based gene targeting.
Chen J; Dai T; Li Q; Xu T; Zhang W; Sun J; Liu H
Stem Cell Res; 2024 Aug; 78():103445. PubMed ID: 38820864
[TBL] [Abstract][Full Text] [Related]
37. Generation of a SMO homozygous knockout human embryonic stem cell line WAe001-A-16 by CRISPR/Cas9 editing.
Wu F; Gao G; Pan T; Yang Z; Xu G; Abbas N; Liu Y; Chen Y; Tan S; You K; Ke X; Zhuang Y; Lin X; Yang F; Li YX
Stem Cell Res; 2018 Mar; 27():5-9. PubMed ID: 29278761
[TBL] [Abstract][Full Text] [Related]
38. Generation of an S100B homozygous knockout pluripotent stem cell line (WAe009-A-94) by the CRISPR/Cas9 system.
Zhang P; Wang H; Li S; Guo T; Zhang R; Zhou P; Ding S
Stem Cell Res; 2022 Oct; 64():102924. PubMed ID: 36182708
[TBL] [Abstract][Full Text] [Related]
39. Generation of a PPP1CA knockout human pluripotent stem cell line via CRISPR/Cas9.
Wang X; Sun J; Fu C; Liu C
Stem Cell Res; 2023 Jun; 69():103077. PubMed ID: 36965407
[TBL] [Abstract][Full Text] [Related]
40. Generation of a TAB2 knockout hESC line (WAe009-A-Z) derived from H9 using CRISPR/Cas9.
Sun W; Li X; Dong J; Zhou Y
Stem Cell Res; 2024 Feb; 74():103284. PubMed ID: 38118206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
